The need to strengthen the evaluation of the impact of Artificial Intelligence-based decision support systems on healthcare provision.

Journal: Health policy (Amsterdam, Netherlands)
Published Date:

Abstract

Despite the renewed interest in Artificial Intelligence-based clinical decision support systems (AI-CDS), there is still a lack of empirical evidence supporting their effectiveness. This underscores the need for rigorous and continuous evaluation and monitoring of processes and outcomes associated with the introduction of health information technology. We illustrate how the emergence of AI-CDS has helped to bring to the fore the critical importance of evaluation principles and action regarding all health information technology applications, as these hitherto have received limited attention. Key aspects include assessment of design, implementation and adoption contexts; ensuring systems support and optimise human performance (which in turn requires understanding clinical and system logics); and ensuring that design of systems prioritises ethics, equity, effectiveness, and outcomes. Going forward, information technology strategy, implementation and assessment need to actively incorporate these dimensions. International policy makers, regulators and strategic decision makers in implementing organisations therefore need to be cognisant of these aspects and incorporate them in decision-making and in prioritising investment. In particular, the emphasis needs to be on stronger and more evidence-based evaluation surrounding system limitations and risks as well as optimisation of outcomes, whilst ensuring learning and contextual review. Otherwise, there is a risk that applications will be sub-optimally embodied in health systems with unintended consequences and without yielding intended benefits.

Authors

  • Kathrin Cresswell
    Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
  • Michael Rigby
    Keele University, School of Social Science and Public Policy, Keele, United Kingdom.
  • Farah Magrabi
    Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, Australia.
  • Philip Scott
    School of Computing, University of Portsmouth, Portsmouth, UK philip.scott@port.ac.uk.
  • Jytte Brender
    Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
  • Catherine K Craven
    Institute for Healthcare Delivery Science, Dept. of Pop. Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, USA; Clinical Informatics Group, IT Department, Mount Sinai Health System, New York, USA.
  • Zoie Shui-Yee Wong
    Graduate School of Public Health, St. Luke's International University, Tokyo, Japan.
  • Polina Kukhareva
    Department of Biomedical Informatics, University of Utah, United States of America.
  • Elske Ammenwerth
    Institute of Medical Informatics, UMIT TIROL - Private University for Health Sciences and Health Technology, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060 Austria.
  • Andrew Georgiou
    Macquarie University, Australian Institute of Health Innovation, Sydney, Australia.
  • Stephanie Medlock
    Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, The Netherlands.
  • Nicolette F de Keizer
    Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Meibergdreef 9, Amsterdam, The Netherlands.
  • Pirkko Nykänen
    Tampere University, Faculty for Information Technology and Communication Sciences, Tampere, Finland.
  • Mirela Prgomet
    Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.
  • Robin Williams
    Institute for the Study of Science, Technology and Innovation, The University of Edinburgh, Edinburgh, United Kingdom.